Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pionyr was founded in 2015 by a UCSF professor and a Genentech alum. Source: BioSpace You Might Also Like <b>GE Ventures</b>, <b>Mayo Clinic Ventures</b> And <b>DFJ</b> Invest $13.75 Million In First Software Platform To Accelerate Cancer Cure Process And Delivery June 19, 2017 Aclaris Scoops Up St. Louis Startup in Deal Worth Up to $100M August 7, 2017 Definiens AG To Host International Symposium For Tissue Phenomics April 11, 2017
<b>GE Ventures</b>, <b>Mayo Clinic Ventures</b> And <b>DFJ</b> Invest $13.75 Million In First Software Platform To Accelerate Cancer Cure Process And Delivery June 19, 2017
